|
Most Women with HIV and Their Health Care Providers Have Not Discussed How HIV Might Affect Them Differently Than Men- Survey Shows Nearly Three-quarters of Women Struggle in Managing their Daily Lives - Atlanta, GA, October 10, 2007 — New findings from the Women Living Positive survey show a communication gap between women living with HIV and their health care providers when it comes to having important discussions about HIV treatment options that meet their individual needs. More than half of the women surveyed (55 percent) say they have never discussed with their health care provider how HIV medications might affect women differently than men. However, the survey also shows that, of the 45 percent who did have this discussion, a majority reported that their health care provider answered questions to their satisfaction and made them feel comfortable discussing the issue (96 percent and 95 percent, respectively). There are now an estimated 300,000 women in the United States living with HIV/AIDS.1 African-American and Hispanic women make up a combined 24 percent of the U.S. female population, yet their communities shouldered an estimated 79 percent of the burden of HIV/AIDS cases among women in 2005.2 In addition, each year more than 6,000 HIV-positive women in the United States give birth.3 “With the rise of HIV infections in women,4 it is important to understand their struggles and unique issues when evaluating their care and treatment options,” says Kathleen Squires, M.D., Director of Infectious Diseases and Environmental Medicine at Thomas Jefferson University Hospital and Professor of Medicine at Jefferson Medical College. “Women living with HIV need to work with their health care provider to discuss important topics including their emotional well-being, family planning considerations and care that best meets their health history and lifestyle." The majority of women diagnosed with HIV in the United States are of childbearing age.5 The survey shows many HIV-positive women and their health care providers aren’t discussing how HIV treatment options might affect a pregnancy until after they conceive. Most women surveyed who are or have been pregnant (57 percent) did not discuss pregnancy and appropriate HIV treatments for pregnancy with their health care provider before becoming pregnant. In addition, a majority of HIV-positive women surveyed report that daily life is a struggle. Approximately three quarters (73 percent) of respondents indicated that living with HIV has caused them to struggle a “great deal” or “somewhat” in managing their daily lives, and 60 percent say living with HIV has made their daily chores and activities more difficult. More than half of respondents (52 percent) identify themselves as caregivers. Forty-three percent of women surveyed feel that living with HIV has made taking care of their families “much more,” or “somewhat more,” difficult. A majority of women surveyed (59 percent) feel that their culture, ethnicity or language impacts the care they receive either “a little” (21 percent) or “a lot” (38 percent). Hispanic (70 percent) and African-American (61 percent) women are more likely than Caucasian (37 percent) women to feel that these factors impact their care. The survey was supported by Boehringer Ingelheim Pharmaceuticals, Inc. and developed in collaboration with The Well Project, a non-profit organization for women affected by HIV. For more information about the Women Living Positive survey, please visit www.thewellproject.org. The site also provides comprehensive information about HIV and provides tools and resources for women living with the disease in English and in Spanish. In addition to the issues discussed above, there are other important topics for HIV-positive women to discuss with their health care provider. These may include cardiovascular disease, diabetes and other chronic medical conditions. Survey Methodology Interviews were conducted in both Spanish and English. Figures for race/ethnicity and region were weighted where necessary to align with the Centers for Disease Control and Prevention (CDC) demographics data for adult HIV-positive women in the United States. Differences between the survey subgroups were tested at a 95 percent confidence level. About The Well Project About Boehringer Ingelheim For more information, please visit http://us.boehringer-ingelheim.com. ContactsAnn Wainright References
|
|